Sharnbasva University students clinch overall championship at Techno Utsav 2025
Students from Sharnbasva University, Kalaburagi, delivered an outstanding performance at Techno Utsav 2025 organised by Lingarajappa Appa Engineering College in Bidar on Thursday emerging as the overall champions of the intercollegiate tech fest.
Competing against participants from various engineering colleges, students from the Faculty of Engineering and Technology (Co-Education) of Sharnbasva University secured the top honours in multiple categories, demonstrating their technical prowess and creative skills.
Laxmi Bagodi, a fourth-semester student from the Department of Computer Science and Engineering (Faculty of Engineering and Technology - Exclusively for Women), won the first prize in the Data Detoxing event.
Her department peers Kadambini, Dharneshwari and Bhargavi clinched the first place in the PPT Presentation competition.
Meanwhile, students from the Faculty of Engineering and Technology (Co-Education) secured the first prize in Photography and second prizes in Group Singing, Circuit Mania and Paper Presentation on Women Empowerment, contributing significantly to the university's overall championship.
Notable winners included Jagadev Reddy, Vineet Biradar, Sunil, Ambaresh and Sangamesh K. whose innovative approach earned them top honours in the Photography category.
Suman secured the second place in Circuit Mania, while Shashank Wali, Sri Giri, and Savita earned the second place for their paper presentation on Women Empowerment.
In Group Singing, Sangamesh and Sai Chetan brought home the second prize.
Awards were distributed during a vibrant valedictory ceremony held at the host college on Thursday evening.
The event was attended by secretary of the Sharanabasaveshwar Vidya Vardhak Sangha Basavaraj Deshmukh, vice-chancellor of Sharnbasva University Anilkumar Bidve and other dignitaries.
The eighth Peetadhipathi of Sharanabasaveshwar Samsthan and Chancellor of Sharnbasva University Sharnbaswappa Appa, chairperson of the Sharanabasaveshwar Vidya Vardhak Sangha Dakshayini Avva and Dean Lakshmi Patil Maka have congratulated the students for their commendable achievement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
5 days ago
- Time of India
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's next-generation cancer immunotherapy, which could take on rival Merck & Co's best-selling drug Keytruda. The deal, which includes $3.5 billion in unconditional payments, underpins BioNTech's ambition to continue a costly long-term focus on experimental cancer treatments and show that its success as Pfizer 's COVID-19 vaccine partner was not a one-off achievement. It also underscores a push across the pharma sector to master a new dual mechanism of action in oncology that activates the immune system - similar to an established drug class including Merck & Co's Keytruda - but which also cuts a tumour's blood supply. BioNTech's German-listed shares surged 16.7% by 1236 GMT to a six-week high. The two companies said in separate statements that the U.S. group will co-develop and co-commercialize BioNTech's drug, BNT327, for multiple solid tumour types. Live Events BioNTech's CEO and co-founder Ugur Sahin said the collaboration will serve "to accelerate and broadly expand BNT327's development to fully realize its potential." The companies said in presentation slides that Bristol Myers was bringing global networks in clinical development and manufacturing to the partnership, among other benefits. BioNTech said in a statement that the partners were seeking to set a new standard of care in the cancer market segment, now dominated by so-called checkpoint inhibitors including Keytruda with $29.5 billion in 2024 sales. Western drugmakers have struck a host of deals to win access to the new drug technology, known as PD-1/VEGF bispecific antibodies, which was pioneered in China. Pfizer last month partnered with China's 3SBio , paying $1.25 billion upfront and up to another $4.8 billion depending on developmental achievements. Merck & Co, whose Keytruda business is under threat from the sector's development push, in November last year licensed an early-stage cancer drug from China-based LaNova Medicines for up to $3.3 billion. "We are now starting to see an industry vote of confidence in the differentiation of this novel mechanism," BMO Capital Markets analysts said in a note. They welcomed BioNTech "partnering with a big pharma name to help manage a broad development plan and potential commercialization". Shares in Instil Bio, which is working with China's ImmuneOnco on a similar compound, soared 24% in U.S. trade on Monday. Summit Therapeutics and China's Akeso have formed another partnership in the development race with a drug candidate called ivonescimab. BioNTech took full ownership of BNT327 through the acquisition of China's Biotheus earlier this year for $800 million upfront and up to $150 million contingent on development achievements. It previously held certain rights in the drug under a 2023 collaboration deal. In addition to an initial payment of $1.5 billion, Bristol plans to pay BioNTech $2 billion in non-contingent anniversary payments through 2028. BioNTech may also earn up to $7.6 billion in development, regulatory and commercial milestones, Bristol said. The companies will share global profits and losses from the drug equally, and joint development and manufacturing costs will also be shared on a 50/50 basis, with some exceptions. BNT327 is being tested as a first-line treatment in extensive stage small cell lung cancer and non-small cell lung cancer. More than 1,000 patients have been treated with the drug to date. Economic Times WhatsApp channel )
Time of India
31-05-2025
- Time of India
IIT Mandi launches AI & Data Science program for all - Know fees, how to register & more
IIT Mandi has launched a new AI and Data Science program for all, even beginners. This specially designed 9-month course provides both foundational and advanced knowledge in AI and Data Science, offering learners a great opportunity to build a career in one of today's most in-demand fields. Interested students can apply at the official website - Let's take a closer look at the IIT Mandi AI and Data Science program, including the registration process, fee structure, syllabus, and more. A Beginner-Friendly Course Designed by Experts at IIT Mandi This AI and Data Science program by the Centre for Continuing Education (CCE), IIT Mandi, is a 15-credit course that is ideal for beginners who have basic knowledge of maths and programming. You don't need to be an expert to apply. What makes this course unique: Created by top IIT Mandi professors Hands-on training in real-world AI and Data Science tools Covers both basic and advanced topics Open to students and professionals from any background Course Duration and Structure Total Duration: 9 Months Trimester Format: 3 trimesters Study Time: Around 10 hours per week Trimester Breaks: Two breaks of 2 weeks each Course Credits: 15 credits (equivalent to a minor degree) Limited Seats Available – Apply Now! Batch Start Date: 3rd June 2025 Seats Remaining: 164 only Make sure to apply early to grab your seat! Simple Admission Process in 3 Easy Steps To join this AI and Data Science program at IIT Mandi, just follow these steps: Clear the Qualifier Test Take the online entrance test at your allotted time. Duration: 60 minutes Topics: Mathematics, Statistics, and Problem-Solving Ability Test is available only once and must be taken on a desktop/laptop using Google Chrome. Complete the Onboarding Shortlisted candidates go through a brief onboarding process. Start Learning Begin your classes and learn from India's top educators at IIT Mandi. How to Register? Visit - Pay Rs 99 to book your test slot. Access a free mock test to practise before the real one. 100% refundable if you don't qualify or decide not to join after counselling. What You'll Learn in This AI and Data Science Program This course covers a wide range of topics from basic concepts to advanced applications: Trimester 1: Mathematics for Data Science Linear Algebra Calculus Probability & Statistics Optimisation Techniques Eigenvectors & Orthogonality Bayes' Theorem and more Trimester 2: Data Science and Machine Learning Supervised & Unsupervised Learning Ensemble Methods Model Evaluation Bias-Variance Trade-off Hyperparameter Tuning Trimester 3: Deep Learning & AI Applications Neural Networks (CNNs, RNNs, Transformers) Generative Models (GANs, VAEs) NLP and Reinforcement Learning Computer Vision Ethics in AI Skills You Will Gain By the end of this AI and Data Science course by IIT Mandi, you will gain: Programming skills Data analysis & visualisation techniques Big data handling Machine Learning & Deep Learning knowledge Real-world problem-solving using AI Who Should Join? This IIT Mandi AI and Data Science program is suitable for: Students looking to enhance their profile while studying Working professionals planning a career switch to AI or Data Science Tech enthusiasts who want to stay ahead in the industry Entrepreneurs and innovators seeking AI-powered solutions Career Opportunities After This Course After completing the program, you can pursue exciting roles like: Data Scientist AI Engineer ML Engineer Software Developer Quantitative Analyst Tech Entrepreneur Why Choose the AI and Data Science Program at IIT Mandi? Top-Notch Faculty from IIT Mandi Comprehensive Curriculum from basics to advanced AI topics Capstone Projects to solve real-life problems Official IIT Mandi Certificate to boost your resume Job-ready skills for high-demand AI and DS careers Fee Structure You can choose between upfront payment or easy EMIs through NBFC partners. The AI and Data Science program by IIT Mandi is your gateway to the booming tech world. With expert guidance, hands-on learning, and a flexible structure, this course can give your career the right boost. If you have a passion for technology and are eager to grow in the field of AI and Data Science, don't miss this opportunity.
The Hindu
30-05-2025
- The Hindu
Campaign aiming for planning for Kharif season 2025 begins
A State-level campaign aimed at facilitating preparatory agricultural planning for the Kharif season 2025 was conducted at Kanakkampalayam village in Gobichettipalayam block on Thursday. The Ministry of Agriculture, Government of India, and the Indian Council of Agricultural Research (ICAR) have jointly proposed to organise the 'Viksit Krishi Sankalp Abhiyan' (VKSP) from May 29 to June 12. The State-level launch event was organised by Krishi Vigyan Kendra (KVK), MYRADA Erode, in the village. R. Thamizh Vendan, Vice-Chancellor in-charge, Tamil Nadu Agricultural University (TNAU), Coimbatore, inaugurated the programme in the presence of A. Velmurugan, Assistant Director General, ICAR–NRM, New Delhi, P. Govindaraj, Director, ICAR–Sugarcane Breeding Institute, Coimbatore, M. Kailasam, Principal Scientist, ICAR–Central Institute of Brackishwater Aquaculture, Chennai, Ravindra Naik, Head, Regional Station, Central Institute of Agricultural Engineering, Coimbatore, P.P. Murugan, Director of Extension Education, TNAU, Coimbatore, and R. Yasothai, Professor and Head, Veterinary University Training and Research Centre, Erode. Delegates visited 14 stalls set up by KVK for the benefit of the farming community. With support from IFFCO, a drone demonstration was conducted to showcase its technological benefits for farmers. During the programme, 17 Information, Education, and Communication (IEC) materials were released, and agricultural inputs were distributed to farmers. The objectives and benefits of various Central and State government schemes were explained to the participating farmers. A total of 542 farmers and entrepreneurs took part in the event.
